Reply to: Understanding treatment options in craniopharyngioma better
- PMID: 32300105
- DOI: 10.1038/s41572-020-0174-0
Reply to: Understanding treatment options in craniopharyngioma better
Comment on
-
Craniopharyngioma.Nat Rev Dis Primers. 2019 Nov 7;5(1):75. doi: 10.1038/s41572-019-0125-9. Nat Rev Dis Primers. 2019. PMID: 31699993 Review.
-
Understanding treatment options in craniopharyngioma better.Nat Rev Dis Primers. 2020 Apr 16;6(1):28. doi: 10.1038/s41572-020-0173-1. Nat Rev Dis Primers. 2020. PMID: 32300107 Free PMC article. No abstract available.
References
-
- Muller, H. L., Merchant, T. E., Warmuth-Metz, M., Martinez-Barbera, J. P. & Puget, S. Craniopharyngioma. Nat. Rev. Dis. Primers 5, 75 (2019). - DOI
-
- Qi, S. Understanding treatment options in craniopharyngioma better. Nat. Rev. Dis. Primers https://doi.org/10.1038/s41572-020-0173-1 (2020). - DOI
-
- Muller, H. L. et al. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur. J. Endocrinol. 165, 17–24 (2011). - DOI
-
- Hidalgo, E. T. et al. Quality of life, hypothalamic obesity, and sexual function in adulthood two decades after primary gross-total resection for childhood craniopharyngioma. Childs Nerv. Syst. 36, 281–289 (2020). - DOI
-
- Fjalldal, S. et al. Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity. Int. J. Obes. 43, 533–544 (2019). - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
